1
Back
Cancer cover

Cancer

IF5.1
Papers20414
Citations62240
Journal Papers 21102
Publication Date
delete
The past, present, and future treatment of BRAFV600-mutant metastatic colorectal cancer: A comprehensive review
deleteCancer
IF5.1
delete2026-08-13
delete0
PREAI
deleteIris Dirven MD; Celina Ang MD; Cleo Bertels MD; Koen Kortbeek MD; Amy de Haar-Holleman MD, PhD; Marieke Vollebergh MD, PhD; Poulikos Poulikakos PhD; Bart Neyns MD, PhD
deleteShare
deleteSave
Clinical outcomes associated with NPM1 mutations in newly diagnosed acute myeloid leukemia
deleteCancer
IF5.1
delete2026-08-13
delete0
deleteOAAI
deleteAziz Farhat MD; Georgina El Hajjar MD; Hagop Kantarjian MD; Koji Sasaki MD, PhD; Nicholas J. Short MD; Branko Cuglievan MD; Sanam Loghavi MD; Keyur Patel MD, PhD; Alex Bataller MD, PhD; Wei Ying Jen MA, BMBCh, MRCP, MMed, FRCPath; Musa Yilmaz MD; Guillermo Montalban-Bravo MD; Danielle Hammond MD; Naveen Pemmaraju MD; Naval Daver MD; Farhad Ravandi MD; Elias Jabbour MD; Tapan Kadia MD; Gautam Borthakur MD; Guillermo Garcia-Manero MD; Courtney D. DiNardo MD; Ghayas C. Issa MD, MS
deleteShare
deleteSave
From screening to support: Structured bibliotherapy and community-based well-being programs as adjuncts to the Older Adults with Cancer-Depression Scale
deleteCancer
IF5.1
delete2026-08-11
delete0
PREAI
deleteCatherine J. Michelutti MPhil; Fergus N. McCormack MPhil
deleteShare
deleteSave
Sexual orientation and gender identity based disparities in colorectal, cervical, and breast cancer screening in the United States
deleteCancer
IF5.1
delete2026-08-11
delete0
deleteOAAI
deleteLorenza Arena MD; Qaidar Alizai MD, MRCS; Abdulaziz Elemosho MD; Odysseas P. Chatzipanagiotou MD; Timothy M. Pawlik MD, MPH, MTS, MBA, PhD
deleteShare
deleteSave
Longitudinal analysis of tyrosine kinase inhibitor therapy outcomes and BCR-ABL1 transcript decline velocity in chronic myeloid leukemia: A 16-year real-world study
deleteCancer
IF5.1
delete2026-08-11
delete0
deleteOAAI
deleteMoaath K. Mustafa Ali MD, MPH; Emily C. Zabor DrPH; Kamilla Abdurakhmanov MS; Hadil Zureigat MD; Ahmed N. Mohamed MD; Muaz Alsabbagh Alchirazi MD; Aastha Dhakal MD; Ali Mushtaq MD; Naveen Rehman MD; Ameed Bawwab MD; Bryan Berube MD; Lana Khatib MD; Akriti G. Jain MD; John C. Molina MD, MEd; Sophia Balderman MD; Abhay Singh MD, MPH; Aaron T. Gerds MD, MS; Ronald Sobecks MD; Anjali S. Advani MD; Hetty E. Carraway MD, MBA; Matt Kalaycio MD; Sudipto Mukherjee MD, PhD, MPH
deleteShare
deleteSave
Early neural signatures of cancer-related fatigue: A longitudinal magnetic resonance imaging study of cortical micro- and macrostructural changes during breast cancer chemotherapy
deleteCancer
IF5.1
delete2026-08-11
delete0
PREAI
deleteYanfei Zhou MS; Jin Liu PhD; Xiao Fu MS; Jian Fan MS; Zong Cao MS; Jing Li MS; Ruiping Ye PhD; Hongzhi Wang MS; Lizhuang Yang PhD; Hai Li PhD
deleteShare
deleteSave
The relationship of neighborhood socioeconomic disadvantage and pretreatment cancer-related cognitive impairment in women with breast cancer: A post hoc analysis of a randomized controlled trial
deleteCancer
IF5.1
delete2026-08-11
delete0
PREAI
deleteAmanda L. Gentry MPH; Susan M. Sereika PhD; Kirk I. Erickson PhD; Maura K. McCall PhD; Sarah M. Belcher PhD; Meredith C. Cummings BSN; Myeong-ga Cho MSN, RN; Eliza Brufsky BS; Margaret Q. Rosenzweig PhD, CRNP-C, AOCNP; Catherine M. Bender PhD, RN
deleteShare
deleteSave
Standardization of postoperative adverse event reporting: A critical opportunity for improvement within the National Clinical Trials Network
deleteCancer
IF5.1
delete2026-08-11
delete0
deleteOAAI
deleteBeth Helmink MD, PhD; Matthew H. G. Katz MD; Chandrajit P. Raut MD, MSc; Sumithra J. Mandrekar PhD; Kristina Laumann BA; Allison Booth MS; Laura Hoffman MA; Eric A. Singer MD, MA, MS; Isabelle Bedrosian MD; Rebecca A. Snyder MD, MPH
deleteShare
deleteSave
Excess risk for cardiovascular and noncardiovascular comorbidities and multimorbidity among patients with myelodysplastic syndrome: A systematic review and meta-analysis
deleteCancer
IF5.1
delete2026-08-11
delete0
deleteOAAI
deleteKonstantinos Liapis MD, PhD; Vasileios Papadopoulos MD, PhD; Iliana Stamatiou MD; Dimitrios Koparanis MS; Lydia Inglezou MD; Emmanouil Panagiotopoulos MD; Bouse Malkots MD; Georgios Vrachiolias MD; Theodoros Spyropoulos MS; Ioannis Kotsianidis MD, PhD
deleteShare
deleteSave
Bendamustine in indolent lymphoma: Letting the dust settle down
deleteCancer
IF5.1
delete2026-08-11
delete0
PREAI
deleteJacopo Olivieri MD, PhD; Valter Gattei MD; Luigino Dal Maso PhD
deleteShare
deleteSave
Assessment of safe chemotherapy handling behaviors among oncology nurses in a conflict-affected setting: A cross-sectional study from Gaza
deleteCancer
IF5.1
delete2026-08-11
delete0
PREAI
deleteAbed El-Rahman Rizq Mohammed Diab RN, MSc; Yousef Ibrahim Aljeesh PhD
deleteShare
deleteSave
EZH2 inhibitor tazemetostat voluntarily withdrawn from market
deleteCancer
IF5.1
delete2026-08-11
delete0
deleteOAAI
deleteLeah Lawrence
deleteShare
deleteSave
The impact of whole lung irradiation in lung metastatic rhabdomyosarcoma: A pooled analysis of two European trials and one European registry
deleteCancer
IF5.1
delete2026-08-11
delete0
deleteOAAI
deleteAmadeus T. Heinz MD; Philip Heesen MD, MSc; Johannes H. M. Merks MD, PhD; Véronique Minard-Colin MD, PhD; Martin Ebinger MD; Alison L. Cameron FRCR; Semi Harrabi MD; Henry Mandeville MD; Reineke A. Schoot MD, PhD; Jörg Fuchs MD; Gabriela Guillen MD, PhD; Ewa Koscielniak MD; Julia C. Chisholm MD; Monika Sparber-Sauer MD; Gianni Bisogno MD
deleteShare
deleteSave
Outcomes of loncastuximab tesirine in heavily pretreated patients with diffuse large B-cell lymphoma, including the post-CAR T-cell therapy setting: A meta-analysis
deleteCancer
IF5.1
delete2026-08-11
delete0
PREAI
deleteFernando Gibran-Nunes MD; Henrique Pêcego MD; Juliana Santos MD; Yasmim Nunes; Bianca Freitas RPh; Jacqueline Rena MD; Marcos Fogale MD; Aliana Ferreira MD; Maria Seiwald MD; Elisabetta Xue MD; Anita Cortez MD; Ana Fonseca PhD; Erick Xavier MD; Mariana Serpa MD; Luciana Tucunduva PhD; Yana Novis MD
deleteShare
deleteSave
New data inform decision-making for breast cancer surgeries
deleteCancer
IF5.1
delete2026-08-11
delete0
deleteOAAI
deleteLeah Lawrence
deleteShare
deleteSave
Real-world effectiveness of chemotherapy regimens after immunotherapy in patients with advanced melanoma in Spain: Results from the GEM1801 study
deleteCancer
IF5.1
delete2026-08-11
delete0
deleteOAAI
deleteMiguel-Ángel Berciano-Guerrero MD, PhD; Elisabeth Pérez-Ruiz MD, PhD; Ainara Soria MD; Javier Medina Martínez MD, PhD; Pablo Ayala de Miguel MD, PhD
deleteShare
deleteSave
Tumor-infiltrating lymphocyte (TIL) therapy: Historical context, clinical applications, and future directions
deleteCancer
IF5.1
delete2026-08-11
delete0
deleteOAAI
deleteShen Li MD; Alexandra E. Rojek MD; Reid Shaw MD; Cristina O’Donoghue MD, MPH; J. Michael Millis MD; Daniel J. Olson MD
deleteShare
deleteSave
Analysis of a large osteosarcoma sequencing data set elucidates patterns of genomic alterations
deleteCancer
IF5.1
delete2026-08-11
delete0
PREAI
deleteHannah G. Bousquet MD; Zheng Kuang MSc; Lorena Lazo de la Vega PhD; Evelina Ceca MBA; Julia Schiantarelli MD; Julius Honecker PhD; Matthew C. Hiemenz MD, MS; Suzanne J. Forrest MD; Katherine A. Janeway MD, MMSc
deleteShare
deleteSave
Large-scale osteosarcoma sequencing reveals age-associated genomic architectures
deleteCancer
IF5.1
delete2026-08-11
delete0
PREAI
deleteZehao Guo MD; Xianbiao Xie MD, PhD
deleteShare
deleteSave
Nivolumab and chemotherapy combination approved for previously untreated Hodgkin lymphoma
deleteCancer
IF5.1
delete2026-08-11
delete0
deleteOAAI
deleteLeah Lawrence
deleteShare
deleteSave